Search research articles
Contact Us
Filters
Showing results (1-10 of 2,772) with videos related to
Page
of 278
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation
|
July 1, 1995
IMx CA 125, an automated microparticle enzyme immunoassay: technical characteristics and clinical usefulness after recalibration
O Mogensen, B Mogensen
Scandinavian Journal of Clinical and Laboratory Investigation
|
October 1, 1992
Measurement of CA 125 by an automated microparticle enzyme immunoassay; comparison with a manual enzyme immunoassay
O Mogensen, B Mogensen
Cancer
|
November 1, 1989
Alpha 1-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125
O Mogensen, B Mogensen, A Jakobsen
Gynecologic Oncology
|
April 1, 1990
Predictive value of CA 125 during early chemotherapy of advanced ovarian cancer
O Mogensen, B Mogensen, A Jakobsen
Gynecologic Oncology
|
August 1, 1990
Tumor-associated trypsin inhibitor and cancer antigen 125 in pelvic masses
O Mogensen, B Mogensen, A Jakobsen
European Journal of Cancer & Clinical Oncology
|
August 1, 1989
CA 125 in the diagnosis of pelvic masses
O Mogensen, B Mogensen, A Jakobsen
Scandinavian Journal of Clinical and Laboratory Investigation
|
May 1, 1989
In vitro stability of the immunoreactivity of the ovarian cancer-associated antigen CA 125
O Mogensen, B Mogensen, A Jakobsen
British Journal of Cancer
|
February 1, 1990
Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours
O Mogensen, B Mogensen, A Jakobsen
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1997
Tissue polypeptide-specific antigen (TPS) as tumour marker in epithelial ovarian cancer
J Blokkebak-Poulsen, O Mogensen, B Mogensen
Acta Obstetricia Et Gynecologica Scandinavica
|
May 20, 2009
Improvement of women's health--HPV vaccination after 16 years of age?
Ole Mogensen
Page
of 278
Search research articles
Search
Showing results (1-10 of 2,772) with videos related to
Sort By:
Page
of 278
Scandinavian Journal of Clinical and Laboratory Investigation
|
July 1, 1995
IMx CA 125, an automated microparticle enzyme immunoassay: technical characteristics and clinical usefulness after recalibration
O Mogensen, B Mogensen
Scandinavian Journal of Clinical and Laboratory Investigation
|
October 1, 1992
Measurement of CA 125 by an automated microparticle enzyme immunoassay; comparison with a manual enzyme immunoassay
O Mogensen, B Mogensen
Cancer
|
November 1, 1989
Alpha 1-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125
O Mogensen, B Mogensen, A Jakobsen
Gynecologic Oncology
|
April 1, 1990
Predictive value of CA 125 during early chemotherapy of advanced ovarian cancer
O Mogensen, B Mogensen, A Jakobsen
Gynecologic Oncology
|
August 1, 1990
Tumor-associated trypsin inhibitor and cancer antigen 125 in pelvic masses
O Mogensen, B Mogensen, A Jakobsen
European Journal of Cancer & Clinical Oncology
|
August 1, 1989
CA 125 in the diagnosis of pelvic masses
O Mogensen, B Mogensen, A Jakobsen
Scandinavian Journal of Clinical and Laboratory Investigation
|
May 1, 1989
In vitro stability of the immunoreactivity of the ovarian cancer-associated antigen CA 125
O Mogensen, B Mogensen, A Jakobsen
British Journal of Cancer
|
February 1, 1990
Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours
O Mogensen, B Mogensen, A Jakobsen
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1997
Tissue polypeptide-specific antigen (TPS) as tumour marker in epithelial ovarian cancer
J Blokkebak-Poulsen, O Mogensen, B Mogensen
Acta Obstetricia Et Gynecologica Scandinavica
|
May 20, 2009
Improvement of women's health--HPV vaccination after 16 years of age?
Ole Mogensen
Page
of 278